ArticleClinics and practice2024

Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study.

Keiko Hata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.